UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006640
Receipt number R000007854
Scientific Title Asymptomatic Moyamoya Registry
Date of disclosure of the study information 2012/01/01
Last modified on 2021/12/03 09:26:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Asymptomatic Moyamoya Registry

Acronym

AMORE

Scientific Title

Asymptomatic Moyamoya Registry

Scientific Title:Acronym

AMORE

Region

Japan


Condition

Condition

Moyamoya disease

Classification by specialty

Neurology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore the epidemiology, clinical features, pathophysiology, and prognosis of asymptomatic moyamoya disease.

Basic objectives2

Others

Basic objectives -Others

To explore the epidemiology, clinical features, pathophysiology, and prognosis of asymptomatic moyamoya disease.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Incidence of all ischemic or hemorrhagic stroke during 5-year follow-up

Key secondary outcomes

1) Incidence of TIA, silent infarct, disease progression, silent micro bleeds, or death during 5-year follow-up
2) Incidence of further ischemic or hemorrhagic stroke, TIA, silent infarct, disease progression, silent micro bleeds, or death during 5-year follow-up


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) 20 to 69 years old
(2) Newly diagnosed as bilateral or unilateral moyamoya disease
(3) no history of TIA or ischemic or hemorrhagic stroke in adulthood
(4) conservatively followed up
(5) modified Rankin scale, 0 or 1
(6) regular follow-up at out-patient clinic
(7) informed consent obtained

Key exclusion criteria

(1) history of TIA or ischemic or hemorrhagic stroke in adulthood
(2) quasi-moamoya disease
(3) contra-indication of MR examination
(4) judged as non-moyamoya disease by Image Analyzing Committee
(5) judged as inappropriate patients by doctor-in-charge

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Kuroda

Organization

University of Toyama

Division name

Neurosurgery

Zip code

930-0194

Address

2630 Sugitani Toyama

TEL

076-434-7348

Email

skuroda@med.u-toyama.ac.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Kuroda

Organization

Toyama University Hospital

Division name

Neurosurgery

Zip code

930-0194

Address

Sugitani 2630, Toyama, Japan

TEL

076-434-7348

Homepage URL


Email

skuroda@med.u-toyama.ac.jp


Sponsor or person

Institute

University of Toyama

Institute

Department

Personal name



Funding Source

Organization

Research Committee on Moyamoya disease

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toyama University Hospital

Address

2630 Sugitani Toyama

Tel

076-434-7348

Email

skuroda@med.u-toyama.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学(北海道)、中村記念病院(北海道)、岩手医科大学(岩手県)、東北大学(宮城県)、東京大学(東京都)、東京女子医科大学(東京都)、東京医科歯科大学(東京都)、千葉循環器病センター(千葉県)、慶応大学(東京都)、北里大学(神奈川県)、名古屋大学(愛知県)、名古屋市立大学(愛知県)、富山大学(富山県)、福井大学(福井県)、京都大学(京都府)、国立循環器病研究センター(大阪府)、大阪大学(大阪府)、岡山大学(岡山県)、九州大学(福岡県)、長崎大学(長崎県)


Other administrative information

Date of disclosure of the study information

2012 Year 01 Month 01 Day


Related information

URL releasing protocol

https://www.jstage.jst.go.jp/article/nmc/55/3/55_ra.2014-0305/_article

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

106

Results

Results date posted

2020 Year 04 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2011 Year 11 Month 01 Day

Date of IRB

2011 Year 10 Month 01 Day

Anticipated trial start date

2012 Year 01 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry

2025 Year 12 Month 31 Day

Date trial data considered complete

2026 Year 06 Month 30 Day

Date analysis concluded

2026 Year 12 Month 31 Day


Other

Other related information

When the enrolled patients experience primary or secondary outcome, the doctors-in-charge must precisely report it to the Research Committee.


Management information

Registered date

2011 Year 11 Month 01 Day

Last modified on

2021 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007854


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name